Home LiteratureArticle Details
PMID: 11723013 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction.

Circulation ·Vol. 104 ·No. 22 ·2001-11-27 ·Pages 2649-52

Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z

Abstract

Shed membrane microparticles circulate in the peripheral blood of nonischemic (NI) patients and patients with myocardial infarction (MI). We investigated whether or not these microparticles would affect endothelium-dependent responses. Rat aortic rings with endothelium were exposed for 24 hours to circulating microparticles isolated from 7 patients with NI syndromes and 19 patients with acute MI. Endothelium-dependent relaxations to acetylcholine were not affected by high concentrations of microparticles from NI patients (P=0.80). However, significant impairment was observed in preparations exposed to microparticles from patients with MI at low and high concentrations, corresponding to 0.7-fold and 2-fold circulating plasma levels (P=0.05 and 0.001, respectively). Impairment was not affected by diclofenac (P=0.47), nor by the cell-permeable superoxide dismutase mimetic Mn(III)tetra(4-benzoic acid) porphyrin chloride (P=0.33), but it was abolished by endothelium removal or by N(omega)monomethyl-L-arginine. Relaxations to the calcium ionophore ionomycin were decreased in rings exposed to microparticles from MI patients (P=0.05 and 0.009 for low and high concentrations, respectively), but microparticles from NI patients had no effect (P=0.81). Finally, high concentrations of microparticles from MI patients affected neither endothelium-independent relaxation to sodium nitroprusside (P=0.59) nor expression of the endothelial nitric oxide synthase (P=0.43). Circulating microparticles from patients with MI selectively impair the endothelial nitric oxide transduction pathway and, therefore, could contribute to the general vasomotor dysfunction observed after MI, even in angiographically normal arteries.

MeSH Terms
Adult Animals Aorta Cell Membrane/metabolism Cell Membrane Structures/metabolism Cyclooxygenase Inhibitors/pharmacology Diclofenac/pharmacology Dose-Response Relationship, Drug Endothelium, Vascular/drug effects,metabolism Enzyme Inhibitors/pharmacology Female Humans In Vitro Techniques Ionophores/pharmacology Male Middle Aged Myocardial Infarction/blood Nitric Oxide/metabolism Nitric Oxide Synthase/antagonists & inhibitors,metabolism Nitric Oxide Synthase Type III Particle Size Rats Rats, Wistar Vasoconstrictor Agents/pharmacology Vasodilator Agents/antagonists & inhibitors,pharmacology Vasomotor System/drug effects,metabolism omega-N-Methylarginine/pharmacology
Chemicals
Cyclooxygenase Inhibitors Enzyme Inhibitors Ionophores Vasoconstrictor Agents Vasodilator Agents Diclofenac omega-N-Methylarginine Nitric Oxide NOS3 protein, human Nitric Oxide Synthase Nitric Oxide Synthase Type III Nos3 protein, rat
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Boulanger C M
INSERM U541, IFR-Circulation, Service de Cardiologie, Hôpital Lariboisière, Paris, France. [email protected]
Scoazec A
Ebrahimian T
Henry P
Mathieu E
Tedgui A
Mallat Z
Article Info
Journal
Circulation
Abbr.
Circulation
ISSN
1524-4539
Published
2001-11-27
Pages
2649-52
Language
English
Region
United States
NLM ID
0147763
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]